StockData
DarioHealth Corp. logo

DarioHealth Corp. (DRIO) stock

DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.46+0.31 (+26.96%)

Close on Nov 18, 2026Market cap $14.31MP/E 0.4Yield –

DarioHealth price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

DarioHealth's price to sales ratio was 0.8× on Nov 10, 2026, against 3.3× a year earlier. Over the last 5 years it ranged from 0.8× to 258.5×, with a median of 35.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20260.8×−2.3
2025Dec 31, 20253.1×−18.2
2024Dec 31, 202421.4×−18.4
2023Dec 29, 202339.8×−34.4
2022Dec 30, 202274.2×−184.3
2021Dec 31, 2021258.5×−50.7
2020Dec 31, 2020309.2×+270.8
2019Dec 31, 201938.4×+35.7
2018Dec 31, 20182.7×−1.0
2017Dec 29, 20173.7×−4.5
2016Dec 30, 20168.2×+6.2
2015Dec 31, 20151.9×–

More DarioHealth figures

See a number that looks wrong?